Notice Pursuant to the National Cooperative Research and Production Act of 1993-fd.io Project, Inc., 29329 [2017-13553]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 123 / Wednesday, June 28, 2017 / Notices
On October 17, 2014, Open Platform
for NFV Project filed its original
notification pursuant to Section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on November 14, 2014 (79 FR
68301).
The last notification was filed with
the Department on March 9, 2017. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on April 4, 2017 (82 FR 16419).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–13555 Filed 6–27–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—fd.io Project, Inc.
Notice is hereby given that, on May
30, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), fd.io Project, Inc.
(‘‘fd.io’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, ZTE Corporation,
Shenzhen, People’s Republic of China,
has been added as a party to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and fd.io intends
to file additional written notifications
disclosing all changes in membership.
On May 4, 2016, fd.io filed its original
notification pursuant to Section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on June 9, 2016 (81 FR 37211).
The last notification was filed with
the Department on March 6, 2017. A
notice was published in the Federal
VerDate Sep<11>2014
17:22 Jun 27, 2017
Jkt 241001
Register pursuant to Section 6(b) of the
Act on March 27, 2017 (82 FR 15240).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–13553 Filed 6–27–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
John Warren Cox, M.D.; Decision and
Order
On February 23, 2017, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to John Warren Cox,
M.D. (Registrant), of West Point,
Mississippi. GX 2. The Show Cause
Order proposed the revocation of
Registrant’s DEA Certificate of
Registration No. BC6115047, on the
ground that he does not have authority
to handle controlled substances in
Mississippi, the State in which he is
registered with the Agency. Id. at 1
(citing 21 U.S.C. 824(a)(3)).
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Registrant is registered with
the DEA as a practitioner authorized to
handle controlled substances in
schedules II through V under DEA
registration BC6115047, at the registered
address of 187 Medical Center Drive,
West Point, Mississippi. Id. The Order
alleged that Registrant’s registration
expires by its terms on August 31, 2019.
Id.
As to the substantive ground for the
proceeding, the Show Cause Order
specifically alleged that on October 18,
2016, Registrant ‘‘voluntarily
surrendered [his] Mississippi medical
license and agreed to never again seek
to be licensed in the State of
Mississippi.’’ Id. The Show Cause Order
further alleged that because Registrant is
currently without authority to practice
medicine or handle controlled
substances in the State of Mississippi,
‘‘the DEA must revoke [his] DEA COR.’’
Id. at 2 (citing 21 U.S.C. 823(f) and
824(a)(3) (other citations omitted)).
The Show Cause Order notified
Registrant of his right to request a
hearing on the allegations, or to submit
a written statement in lieu of a hearing,
the procedure for electing either option,
and the consequence for failing to elect
either option. Id. at 2 (citing 21 CFR
1301.43). It also notified him of his right
to submit a corrective action plan in
accordance with 21 U.S.C. 824(c)(2)(C).
Id. at 2–3.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
29329
On February 24, 2017, a Diversion
Investigator from the Jackson,
Mississippi District Office personally
served the Show Cause Order on
Registrant at his residence in West
Point, Mississippi. GX 4 (Declaration of
Diversion Investigator).
On May 5, 2017, the Government
forwarded its Request for Final Agency
Action (RFAA) and an evidentiary
record to my Office. Therein, the
Government represents that Registrant
‘‘has not filed a request for a hearing or
a written statement, and more than 30
days ha[ve] now passed since he was
served.’’ RFAA, at 1–2.
Based on the Government’s
representation that more than 30 days
have now passed since the date of
service of the Show Cause Order and
that Registrant has not submitted a
request for a hearing or a written
statement, I find that Registrant has
waived his right to a hearing or to
submit a written statement in lieu of a
hearing. 21 CFR 1301.43(d). I therefore
issue this Decision and Final Order
based on relevant evidence contained in
the record submitted by the
Government. Id. § 1301.43(d) & (e). I
make the following findings of fact.
Findings
Registrant is the holder of DEA
Registration No. BC6115047, pursuant
to which he is authorized to dispense
controlled substances in Schedules II
through V as a practitioner, at the
registered address of 187 Medical Center
Drive, West Point, Mississippi. GX 1
(Certification of Registration History).
His registration does not expire until
August 31, 2019. Id.
On October 18, 2016, Registrant
voluntarily surrendered his license to
practice medicine in the State of
Mississippi, and ‘‘agree[d] to never seek
application for a future license to
practice medicine in the State of
Mississippi.’’ GX 3, at 2 (Surrender of
Medical License). The agreement to
voluntarily surrender his license
followed an investigation by the
Investigative Division of the Mississippi
State Board of Medical Licensure, which
‘‘ha[d] in its possession evidence which,
if produced during the course of an
evidentiary hearing, would show [that
Registrant’s] continued practice
constitutes a threat to the public health
and safety due to his impairment.’’ Id.
at 2. Registrant’s surrender became
effective immediately upon execution of
the surrender form on October 18, 2016.
Id.
A printout from the Mississippi
Board’s Physician Profile System, dated
May 5, 2017, shows that Registrant’s
license to practice medicine ‘‘expired’’
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 82, Number 123 (Wednesday, June 28, 2017)]
[Notices]
[Page 29329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13553]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--fd.io Project, Inc.
Notice is hereby given that, on May 30, 2017, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), fd.io Project, Inc. (``fd.io'')
has filed written notifications simultaneously with the Attorney
General and the Federal Trade Commission disclosing changes in its
membership. The notifications were filed for the purpose of extending
the Act's provisions limiting the recovery of antitrust plaintiffs to
actual damages under specified circumstances. Specifically, ZTE
Corporation, Shenzhen, People's Republic of China, has been added as a
party to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and fd.io intends to file additional
written notifications disclosing all changes in membership.
On May 4, 2016, fd.io filed its original notification pursuant to
Section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to Section 6(b) of the Act on June 9,
2016 (81 FR 37211).
The last notification was filed with the Department on March 6,
2017. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on March 27, 2017 (82 FR 15240).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-13553 Filed 6-27-17; 8:45 am]
BILLING CODE P
